Search
Adial Pharmaceuticals Inc
ADILAdd to Watchlist
2.900USD
+0.090+3.20%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
4.38MMarket Cap
LossP/E TTM
View Detailed Chart
TradingKey 图表Intraday
1m
30m
1h
D
W
M
D
Today
+3.20%
5 Days
+13.28%
1 Month
+19.83%
6 Months
+1111.87%
Year to Date
+1218.18%
1 Year
+787.12%
Key Figures
2.840Open
2.940High
73.72KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
4.88%Turnover Ratio
2.810Prev. Close
2.710Low
169.05KTurnover
LossP/E Static
1.18P/B
0.00%Div Yield TTM
-179.08%ROA
18.90052wk High
2.17Volume Ratio
-13.20MNet Profit
1.51MShares
-291.2213EPS TTM
1.45Beta
-265.94%ROE
1.31052wk Low
8.19%Amplitude
--Gross Margin
4.38MMarket Cap
2.76Reward/Risk
5.85%Risk Rate
TradingKey Stock Score
No stock score available due to insufficient data.
Adial Pharmaceuticals Inc News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Adial Pharmaceuticals Inc Info
Adial Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development of therapies for the treatment and prevention of addiction and related disorders. The Company’s lead investigational new drug product, AD04, is a genetically targeted, serotonin-3 receptor antagonist, therapeutic agent for the treatment of Alcohol Use Disorder (AUD) in heavy drinking patients and was recently investigated in the Company’s ONWARD pivotal Phase III clinical trial for the potential treatment of AUD in subjects with certain target genotypes identified using the Company’s proprietary companion diagnostic genetic test. AD04 is also used for the treatment of other addictive disorders, such as Opioid Use Disorder, obesity, smoking, and other drug addictions. The Company’s wholly owned subsidiary is Purnovate, Inc.
Ticker SymbolADIL
CompanyAdial Pharmaceuticals Inc
CEOClaiborne (Cary J)
Websitehttps://www.adialpharma.com/
Related Instruments
+1.62%
+3.50%
+6.14%
+3.96%
+3.31%
+3.72%
+3.55%
+3.40%
+4.21%
+1.80%
+6.03%
+4.11%
+4.62%
+3.68%
+2.35%
0.00%
+4.73%
+3.32%
+0.41%
+4.98%Popular Instruments
52852.900
+10.400 (+0.02%)
29669.900
+358.500 (+1.22%)
7507.800
+36.300 (+0.49%)
14963.000
+160.000 (+1.08%)
69676.000
+1528.000 (+2.24%)
6412.400
+59.600 (+0.94%)
68.683
+0.339 (+0.50%)
308.630
+14.250 (+4.84%)
194.830
-2.750 (-1.39%)
4174.610
+52.700 (+1.28%)
FAQs
What is the current price of Adial Pharmaceuticals Inc (ADIL)?
The current price of Adial Pharmaceuticals Inc (ADIL) is 2.90.
What is the symbol of Adial Pharmaceuticals Inc?
The ticker symbol of Adial Pharmaceuticals Inc is ADIL.
What is the 52-week high of Adial Pharmaceuticals Inc?
The 52-week high of Adial Pharmaceuticals Inc is 18.90.
What is the 52-week low of Adial Pharmaceuticals Inc?
The 52-week low of Adial Pharmaceuticals Inc is 1.31.
What is the market capitalization of Adial Pharmaceuticals Inc?
The market capitalization of Adial Pharmaceuticals Inc is 4.38M.
Is Adial Pharmaceuticals Inc (ADIL) currently rated as Buy, Hold, or Sell?
According to analysts, Adial Pharmaceuticals Inc (ADIL) has an overall rating of Buy, with a price target of 7.00.
What is the Earnings Per Share (EPS TTM) of Adial Pharmaceuticals Inc (ADIL)?
The Earnings Per Share (EPS TTM) of Adial Pharmaceuticals Inc (ADIL) is -298.27.